Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100GlobeNewsWire • 12/13/22
Israeli Biotech Clearmind Medicine Appoints ex-Red Bull Executive Special Advisor for Developing MEAI as Alcohol SubstituteGlobeNewsWire • 12/09/22
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical TrialGlobeNewsWire • 11/23/22
Aegis Capital Corp. Acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind Medicine Inc. (NASDAQ: CMND)Accesswire • 11/17/22
Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital MarketGlobeNewsWire • 11/17/22